Retatrutide 20mg (R&D Only)
Retatrutide 20mg is an advanced research peptide designed for scientific investigations into metabolic regulation, hormone receptor signalling, peptide pharmacology, and endocrine biology. Due to its unique ability to activate three separate receptor systems, Retatrutide has become one of the most discussed compounds within peptide research and development.
Unlike earlier peptide compounds that target a single receptor pathway, Retatrutide interacts with:
- GLP-1 (Glucagon-Like Peptide-1) Receptors
- GIP (Glucose-Dependent Insulinotropic Polypeptide) Receptors
- Glucagon Receptors
This triple-agonist mechanism has generated significant interest among researchers studying complex metabolic and endocrine signalling pathways.
What Is Retatrutide?
Retatrutide is a synthetic peptide engineered to simultaneously activate GLP-1, GIP, and glucagon receptors. This unique receptor profile distinguishes it from first-generation and second-generation metabolic peptides.
Researchers continue to investigate Retatrutide for its role in:
- Metabolic signalling pathways
- Hormonal communication systems
- Receptor pharmacology
- Endocrine research
- Peptide engineering
- Cellular energy regulation studies
Its innovative design has positioned Retatrutide as one of the leading compounds within next-generation peptide research.
Key Features
20mg Research-Grade Formula
Each vial contains:
- 20mg Retatrutide
- Research Grade Purity
- High-Quality Lyophilised Powder
- Laboratory Specification Manufacturing
Triple Receptor Agonist
Retatrutide simultaneously targets:
- GLP-1 receptors
- GIP receptors
- Glucagon receptors
This broad receptor activity provides researchers with opportunities to explore multiple biological pathways within a single study model.
Premium Research Quality
Manufactured using strict quality-control standards to support consistency and reliability throughout laboratory investigations.
Suitable for Advanced Research
Ideal for:
- Metabolic studies
- Receptor signalling research
- Peptide development projects
- Formulation optimisation
- Pharmacological investigations
- Endocrine pathway analysis
Research Applications
Metabolic Research
Retatrutide is extensively investigated in studies examining metabolic regulation, receptor interactions, and signalling pathways.
GLP-1 Receptor Studies
Researchers utilise Retatrutide to evaluate receptor activation mechanisms and downstream signalling processes associated with GLP-1 pathways.
GIP Research
The compound is commonly included in studies involving glucose-dependent insulinotropic polypeptide receptor activity and biological responses.
Glucagon Receptor Investigations
Retatrutide’s glucagon receptor activity provides valuable opportunities for exploring complex endocrine signalling systems.
Peptide Pharmacology Research
Researchers frequently investigate:
- Receptor-binding properties
- Pharmacodynamic behaviour
- Peptide stability
- Biological activity profiles
Formulation Development
Suitable for studies involving:
- Compound stability
- Delivery systems
- Peptide optimisation
- Research formulation projects
Why Choose Retatrutide 20mg?
Advanced Triple Agonist Technology
Retatrutide represents one of the most sophisticated peptide structures currently available for metabolic and endocrine research.
High Scientific Interest
Researchers worldwide continue to investigate Retatrutide due to its unique receptor profile and broad research potential.
Research Grade Manufacturing
Produced under strict laboratory-quality standards to ensure consistency, purity, and reliability.
Versatile Research Applications
Applicable across numerous scientific disciplines including:
- Metabolic biology
- Endocrinology
- Receptor pharmacology
- Peptide science
- Cellular signalling
- Drug development research
Storage Information
For optimal stability:
- Store refrigerated between 2°C and 8°C
- Protect from direct sunlight
- Avoid excessive heat exposure
- Keep vial tightly sealed
- Follow laboratory handling procedures
Proper storage helps maintain peptide integrity and long-term research reliability.
Important Disclaimer
For Research & Development Use Only. Not intended for human consumption, diagnosis, treatment, cure, or prevention of disease. This product is supplied exclusively for laboratory research and must only be handled by qualified professionals.
Product Specifications
| Specification | Details |
|---|---|
| Product Name | Retatrutide 20mg |
| Active Compound | Retatrutide |
| Strength | 20mg |
| Format | Lyophilised Powder |
| Category | Triple Agonist Research Peptide |
| Grade | Research Grade |
| Receptor Targets | GLP-1, GIP, Glucagon |
| Storage | 2°C–8°C Recommended |
| Application | Research Use Only |
Frequently Asked Questions
What is Retatrutide 20mg?
Retatrutide 20mg is a research-grade peptide designed for laboratory investigations involving GLP-1, GIP, and glucagon receptor signalling pathways.
What makes Retatrutide unique?
Retatrutide is a triple receptor agonist, meaning it interacts with three separate receptor systems rather than just one.
What research areas use Retatrutide?
Researchers commonly investigate Retatrutide in metabolic studies, endocrine research, receptor pharmacology, peptide science, and formulation development.
What format is Retatrutide supplied in?
The product is supplied as a lyophilised research-grade powder suitable for laboratory use.
How should Retatrutide be stored?
Store refrigerated between 2°C and 8°C and protect from heat, moisture, and direct sunlight.
Is Retatrutide intended for human use?
No. This product is supplied exclusively for research and development applications.





Reviews
There are no reviews yet.